孤立性扩张乳管再探讨:恶性率与管理意义
该研究回顾性分析11年间49例孤立性扩张乳管(SDD)的乳腺影像检查,评估BI-RADS分类、恶性率及与高危/恶性病变相关的影像特征。结果显示恶性率仅2%,所有无回声SDD均为良性,而伴肿块或内部血流的SDD与高危/恶性结局相关,提示无回声SDD可随访,伴肿块或血流者需活检。
要点
- 无回声的孤立性扩张乳管均为良性,可考虑随访而非立即活检。
- SDD伴肿块或内部血流时,高危/恶性风险显著增加,应建议活检。
- BI-RADS第5版推荐对无明确良性病因的SDD进行活检,但实际恶性率低(2%)。
关键影像表现/征象
- 无回声SDD均为良性(n=13)。
- 所有良性SDD均缺乏内部血流。
- SDD伴肿块与恶性/高危结局相关(多因素分析p < .001)。
诊断标准与关键数值
- SDD定义为单侧不对称扩张的乳腺导管,直径大于2 mm。
- BI-RADS分类:BI-RADS 4/5占63%(31/49),BI-RADS 3占18%(9/49),BI-RADS 2占18%(9/49)。
- 活检病变中良性占52%(16/31),高危占48%(15/31,均为乳头状病变);恶性率1/49(2%)。
临床应用与阅片要点
- 阅片时注意评估SDD是否伴肿块或内部血流,这些特征提示需活检。
- 无回声SDD可考虑随访,避免不必要的活检。
- BI-RADS第5版推荐对无明确良性病因的SDD活检,但实际恶性率低,应结合影像特征分层管理。
局限性
- 回顾性研究设计。
- 样本量较小(49例)。
- 单机构多站点研究,实践模式可能变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: A solitary dilated duct (SDD) is a single asymmetrically dilated breast duct with diameter more than 2 mm. The Breast Imaging Reporting and Data System (BI-RADS) fifth edition recommends additional imaging and biopsy for SDDs without demonstrated benign etiology, however management of this rare entity remains controversial. This study describes practice patterns, malignancy rate, and features associated with high-risk/malignant SDDs to better stratify patients requiring biopsy versus follow-up.
MATERIALS AND METHODS: This IRB-approved retrospective study identified mammographic, sonographic and MRI exams utilizing the term "solitary dilated duct" at a multisite academic institution between 1/1/2010 and 12/31/2020. Clinical and imaging features, BI-RADS assessments, and outcomes were analyzed. Univariate and multivariate analyses identified predictors of high-risk/malignant histology.
RESULTS: SDDs identified in 49 women (mean age 56.1 years) were assessed as BI-RADS 4/5 (31/49, 63%), BI-RADS 3 (9/49, 18%), or BI-RADS 2 (9/49, 18%). Most sampled lesions were benign (16/31, 52%) and the remaining were high-risk (15/31, 48%, all papillary lesions). The only papilloma with atypia on core biopsy upgraded to grade 2 DCIS on excision (malignancy rate 1/49, 2%). All anechoic SDDs were benign (n=13), and all benign SDDs lacked internal vascularity. SDDs with associated masses were associated with malignant/high-risk outcomes on multivariate analysis (p < .001).
CONCLUSION: The BI-RADS fifth edition recommends biopsy for SDDs without demonstrated benign etiology. In our 11-year study period, practice patterns were variable with a low malignancy rate of 2%. Our findings suggest that anechoic SDDs may be followed, and SDDs with associated masses or internal vascularity require biopsy.
引用
- Panigrahi, Fernandes, Mullen, et al. Solitary Dilated Ducts Revisited: Malignancy Rate and Implications for Management. Acad Radiol. 2022. PMID: 36115737. doi:10.1016/j.acra.2022.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。